Related Experiment Video
Updated: Jun 8, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Factors affecting improved glycaemic control in youth using insulin pumps
J Wilkinson1, K McFann, H P Chase
1University of Colorado, Aurora, CO, USA.
Diabetic Medicine : a Journal of the British Diabetic Association
|September 22, 2010
Summary
Frequent blood glucose testing and increased insulin bolus use are key to improving glycemic control in young people with Type 1 diabetes. Optimizing temporary basal rates also aids in lowering HbA1c levels.
Area of Science:
- Pediatric Endocrinology
- Diabetes Technology
- Metabolic Disorders
Background:
- Type 1 diabetes mellitus (T1DM) management in youth requires optimizing insulin therapy.
- Insulin pump therapy (IPT) offers flexible glucose control but requires user engagement.
- Glycemic control, measured by HbA1c, remains a critical factor in preventing long-term T1DM complications.
Purpose of the Study:
- To identify factors associated with insulin pump use that lead to lower HbA1c levels in pediatric T1DM patients.
- To explore the relationship between specific insulin pump usage patterns and glycemic outcomes.
- To provide evidence-based recommendations for improving T1DM management in adolescents using insulin pumps.
Main Methods:
- Analysis of data from 150 youth (ages 5-20) with T1DM using insulin pumps.
- Correlation of changes in insulin pump usage parameters with changes in HbA1c levels over 3-month intervals for 85 participants.
- Logistic regression to identify predictors of significant HbA1c improvement (≥0.5%).
Main Results:
- Lower HbA1c levels correlated with more frequent daily insulin boluses (r=-0.46) and more frequent blood glucose checks (r=-0.35).
- Youth with HbA1c <7.5% demonstrated significantly higher frequency of blood glucose testing and bolusing compared to those with higher HbA1c.
- Increased bolus insulin (OR=1.15) and greater use of temporary basal rates (OR=1.017) predicted a decrease in HbA1c levels.
Conclusions:
- Frequent blood glucose monitoring and timely insulin bolus administration are crucial for effective glycemic management in T1DM youth on insulin pumps.
- Increasing the duration of temporary basal rate use is associated with improved glycemic control.
- These findings highlight the importance of user behavior and specific device settings in optimizing T1DM management with insulin pump therapy.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...